Stern R B, Williams R
Postgrad Med J. 1974 Jun;50(584):392-4. doi: 10.1136/pgmj.50.584.392.
Three types of hepatitis are seen in children—acute viral hepatitis, active chronic hepatitis and the neonatal hepatitis syndrome. Few adequate controlled clinical trials of immunosuppressive therapy have been performed in these conditions, and none specifically in children. Many trials in the 1950s using corticosteroids were performed in acute viral hepatitis. Some showed that steroids were superior to controls and some showed no difference. Later trials confirmed that steroids were of no benefit in uncomplicated viral hepatitis, and further trials are now unjustifiable. Active chronic hepatitis is seen in all age groups, and there is little clear-cut evidence that the disease differs significantly in children from adults. Three well controlled clinical trials using immunosuppressive agents have been performed in this condition, but all were predominantly in adults. The conclusions were that steroids are the treatment of choice, although azathioprine may have a steroid-sparing effect. No prospective controlled trials of immunosuppressives have been carried out in the neonatal hepatitis syndrome, and in view of the variable prognosis there is an urgent need for one to be carried out. Large numbers, and a long follow-up period would be necessary and the trial need not be performed doubleblind.
儿童中可见三种类型的肝炎——急性病毒性肝炎、活动性慢性肝炎和新生儿肝炎综合征。在这些情况下,很少有充分对照的免疫抑制治疗临床试验,而且没有专门针对儿童进行的试验。20世纪50年代许多使用皮质类固醇的试验是在急性病毒性肝炎中进行的。一些试验表明类固醇优于对照组,而一些试验则显示没有差异。后来的试验证实,类固醇对无并发症的病毒性肝炎没有益处,现在进一步试验是不合理的。活动性慢性肝炎可见于所有年龄组,几乎没有明确证据表明该疾病在儿童和成人中有显著差异。在这种情况下已经进行了三项使用免疫抑制剂的对照良好的临床试验,但所有试验主要针对成人。结论是,类固醇是首选治疗方法,尽管硫唑嘌呤可能有减少类固醇用量的作用。尚未对新生儿肝炎综合征进行免疫抑制剂的前瞻性对照试验,鉴于预后不一,迫切需要进行这样一项试验。需要大量样本和较长的随访期,而且该试验不必采用双盲法。